Literature DB >> 32885391

Multidimensional assessment of cervical spondylotic myelopathy patients. Usefulness of a comprehensive score system.

Fabio Pilato1, Rosalinda Calandrelli2, Marisa Distefano3, Francesco Ciro Tamburrelli4,5.   

Abstract

OBJECTIVE: Cervical spondylotic myelopathy (CSM) is caused by cervical spine degeneration and surgery may be beneficial, but selection for surgery might be challenging. We performed a multimodal analysis to assess predicting factors that may be useful to help surgeons in this choice. PATIENTS AND METHODS: We retrospectively evaluated clinical, motor evoked potentials (MEP), and MRI data of patients who undergone surgery for CSM. Seventy-six consecutive patients (46 males) were enrolled. The median age was 65.5 [IQR: 57-71] years, and the duration of symptoms was 11 [8-13] months. A multivariate analysis in order to assess predictors of outcome and ROC curve analysis were performed.
RESULTS: Thirty patients (M:18, 39.5%) gained 6 or more points on mJOA and they were collected in good recovery group, whereas 46 patients (60.5%, M:28) showed a fair recovery. We developed a comprehensive score system (CSS) taking into account clinical, neurophysiological, and neuroradiological data. ROC curve analysis was performed to determine the discriminative power of four models derived from the multivariate logistic regression analysis for predictors of good outcome considering only clinical variables, MRI variables, and MEP variables or considering the comprehensive model, demonstrating a good accuracy of CSS model to predict outcome.
CONCLUSION: This study demonstrates that CSS model taking into consideration functional assessment by mJOA score, neurologic evaluation, cervical MRI, and MEP may be a feasible method to predict outcome in patients candidate to surgery, supporting surgeon's decisions both for those patients candidate to surgery and for patients in whom a "wait and see" approach could be proposed.

Entities:  

Keywords:  Cervical spondylotic myelopathy; Magnetic resonance imaging; Motor-evoked potentials; Myelopathy; Personalized medicine; Prognosis

Mesh:

Year:  2020        PMID: 32885391      PMCID: PMC7956005          DOI: 10.1007/s10072-020-04691-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  5 in total

1.  Somatosensory evoked potentials in the diagnosis of cervical spondylotic myelopathy.

Authors:  D Restuccia; V Di Lazzaro; M Lo Monaco; A Evoli; M Valeriani; P Tonali
Journal:  Electromyogr Clin Neurophysiol       Date:  1992 Jul-Aug

Review 2.  Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis.

Authors:  Eli M Baron; William F Young
Journal:  Neurosurgery       Date:  2007-01       Impact factor: 4.654

3.  Cervical spondylotic myelopathy: proposal of a surveillance algorithm.

Authors:  F Tamburrelli; V Di Lazzaro; E Pola; M Genitiempo; F Pilato; C A Logroscino
Journal:  Eur Rev Med Pharmacol Sci       Date:  2008 May-Jun       Impact factor: 3.507

4.  The use of evoked potentials for clinical correlation and surgical outcome in cervical spondylotic myelopathy with intramedullary high signal intensity on MRI.

Authors:  R K Lyu; L M Tang; C J Chen; C M Chen; H S Chang; Y R Wu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

5.  Relationship Between Signal Changes on T2-weighted Magnetic Resonance Images and Cervical Dynamics in Cervical Spondylotic Myelopathy.

Authors:  Lipeng Yu; Zitao Zhang; Qingfeng Ding; Yiming Li; Yuwen Liu; Guoyong Yin
Journal:  J Spinal Disord Tech       Date:  2015-07
  5 in total
  2 in total

1.  Logistic Model and Gradient Boosting Machine Model for Physical Therapy of Lumbar Disc Herniation.

Authors:  Ping Zhao; Jin Xue; Xiaomei Xu; Lifei Wang; Dan Chen
Journal:  Comput Math Methods Med       Date:  2022-05-11       Impact factor: 2.809

2.  Clinical Efficacy and Safety of Anterior Cervical Decompression versus Segmental Fusion and Posterior Expansive Canal Plasty in the Treatment of Multilevel Cervical Spondylotic Myelopathy.

Authors:  Chen Xia; Fangfang Shi; Chuyong Chen; Jun Lv; Qi Chen
Journal:  J Healthc Eng       Date:  2022-04-11       Impact factor: 3.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.